Geode Capital Management »

Entrada Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.9M 439k 15.80
2023-06-30 $6.1M 401k 15.14
2023-03-31 $2.7M 184k 14.50
2022-12-31 $2.5M 182k 13.52
2022-09-30 $2.6M 167k 15.76
2022-06-30 $1.2M 102k 12.17
2022-03-31 $1.7M 178k 9.38
2021-12-31 $2.8M 162k 17.12